Bulletin
Investor Alert

New York Markets Close in:

Sarepta Therapeutics Inc.

NAS: SRPT

GO
/marketstate/country/us

Market open

/zigman2/quotes/206140855/composite

$

142.86

Change

+5.10 +3.70%

Volume

Volume 274,705

Sep 25, 2020, 12:17 p.m.

Real time quotes

/zigman2/quotes/206140855/composite

Previous close

$ 137.76

$ 142.86

Change

+5.10 +3.70%

Day low

Day high

$135.01

$143.17

Open
Open: 137.96

52 week low

52 week high

$72.62

$175.00

Open

Market cap

$10.81B

Average volume

720,092

P/E ratio

N/A

Rev. per Employee

$603,274

EPS

-7.03

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/srpt

MarketWatch News on SRPT

  1. How Pfizer Plans to Lead the Industry in Gene Therapies

    10:29 a.m. Sept. 16, 2020

    - Barron's Online

  2. Pfizer Highlights Dozens of Drugs in Its Pipeline

    10:23 a.m. Sept. 15, 2020

    - Barron's Online

  3. FDA Delays Start of Sarepta’s Gene Therapy Trial

    10:24 a.m. Sept. 10, 2020

    - Barron's Online

  4. 5 Biotech Stocks That Could Be Worth a Look

    10:44 p.m. Aug. 26, 2020

    - Barron's Online

  5. Sarepta Therapeutics Stock Is Now a Top Idea at J.P. Morgan

    4:46 p.m. Aug. 25, 2020

    - Barron's Online

  6. Sarepta Therapeutics started at outperform with a $60 price target at Raymond James

    8:24 a.m. Aug. 25, 2020

    - Tonya Garcia

  7. Here’s a hedge fund strategy that just might work for you

    1:15 p.m. June 27, 2020

    - Andrea Riquier

  8. Sarepta Therapeutics Revives Anti-Viral Program for Covid-19

    6:16 a.m. April 29, 2020

    - Barron's Online

  9. Coronavirus Is Bad — and Good — for Biotech Stocks

    5:52 p.m. March 10, 2020

    - Barron's Online

  10. Sarepta Got a Scathing FDA Rejection and Its Stock Is Falling

    11:19 a.m. Jan. 23, 2020

    - Barron's Online

  11. The Biotech Sector Is Roaring Into 2020. Here’s Why.

    2:20 p.m. Dec. 27, 2019

    - Barron's Online

  12. Sarepta Stock Is Soaring on $1 Billion Deal With Roche

    10:13 a.m. Dec. 23, 2019

    - Barron's Online

  13. Sarepta Stock Soars on Roche Deal, and the Dow Is Higher Again

    9:06 a.m. Dec. 23, 2019

    - Barron's Online

  14. Sarepta shares up 13% on news of Roche deal

    8:21 a.m. Dec. 23, 2019

    - MarketWatch.com

  15. Solid Biosciences stock are up on DMD study news

    9:38 a.m. Dec. 18, 2019

    - Jaimy Lee

  16. Sarepta Stock Is Spiking as FDA Reverses Course, Approving Drug

    10:01 a.m. Dec. 13, 2019

    - Barron's Online

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/srpt

Other News on SRPT

  1. Buy the dip in biotechs - RBC

    3:34 p.m. Sept. 21, 2020

    - Seeking Alpha

  2. Seeking Alpha Catalyst Watch

    3:30 p.m. Sept. 18, 2020

    - Seeking Alpha

  3. How Moderna Will Fare After Posting Strong Clinical Results

    3:37 a.m. Aug. 28, 2020

    - Seeking Alpha

  4. Sarepta's Casimersen NDA Gets Priority Review From FDA

    11:36 a.m. Aug. 26, 2020

    - Zacks.com

  5. Dyne Therapeutics on deck for IPO

    6:36 a.m. Aug. 26, 2020

    - Seeking Alpha

  6. Needham Issues a Buy Rating on Sarepta Therapeutics (SRPT)

    12:35 p.m. Aug. 25, 2020

    - SmarterAnalyst

  7. FDA accepts Sarepta application for DMD med casimersen

    8:54 a.m. Aug. 25, 2020

    - Seeking Alpha

  8. Why I'm Worrying Over A Market Drop

    4:22 p.m. Aug. 17, 2020

    - Seeking Alpha

  9. FDA OK NS Pharma's viltolarsen for certain Duchenne patients

    3:24 p.m. Aug. 12, 2020

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/srpt

Press Releases on SRPT

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.